Jomtana Siripaibun, Director of Oncology Center of Chulabhorn Hospital, shared a post on LinkedIn:
“Last weekend, I had the opportunity to speak at the AstraZeneca Oncology Summit in Vietnam,
sharing perspectives on digital transformation in MDT with oncology colleagues in both Hanoi and Ho Chi Minh City.
MDT in cancer care is not just about making decisions.
It is about alignment under uncertainty.
Evidence is clear: structured MDT significantly improves survival.
The question is no longer whether MDT works — but whether we can deliver it consistently, at scale.
In practice, MDT often breaks down due to fragmented data, incomplete preparation, and lack of structured follow-up.
This is not a documentation problem.
It is a system design problem.
As patient volume continues to rise
and oncology enters the era of precision medicine, traditional workflows are no longer sufficient.
Digital transformation is not an add-on — it is a structural redesign of MDT, enabling:
- integrated data visibility
- standardized case discussion
- accountable decision tracking
The future of cancer care depends not only on expertise —
but on the systems that enable better multidisciplinary decisions.”
